Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$906.54 USD
-0.78 (-0.09%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $908.24 +1.70 (0.19%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: BMO |
3/2024 | $10.09 | -0.79% |
Earnings Summary
For their last quarter, Regeneron Pharmaceuticals (REGN) reported earnings of $11.86 per share, beating the Zacks Consensus Estimate of $10.43 per share. This reflects a positive earnings surprise of 13.71%. Look out for REGN's next earnings release on May 02, 2024. For the next earning release, we expect the company to report earnings of $10.09 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for REGN
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
REGN: What are Zacks experts saying now?
Zacks Private Portfolio Services